Alessandro Pulsoni | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Surface antigen serocleared hepatitis B virus infection increases the risk of mixed cryoglobulinemia vasculitis in male patients with chronic hepatitis C	FRONTIERS IN IMMUNOLOGY	2024
Leucocytosis during induction therapy with all-trans-retinoic acid and arsenic trioxide in acute promyelocytic leukaemia predicts differentiation syndrome and treatment-related complications	BRITISH JOURNAL OF HAEMATOLOGY	2024
Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia	CANCERS	2024
LEUKOCYTOSIS IN LOW-INTERMEDIATE RISK ACUTE PROMYELOCYTIC LEUKEMIA DURING ATRA-ATO INDUCTION THERAPY: A REAL-LIFE STUDY	HEMASPHERE	2024
Whole body MRI with Difusion Weighted Imaging versus 18F‑fuorodeoxyglucose‑PET/CT in the staging of lymphomas	LA RADIOLOGIA MEDICA	2023
Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas	LA RADIOLOGIA MEDICA	2023
Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and Beyond	CANCERS	2023
Impact of immunochemotherapy with R‐bendamustine or R‐CHOP for treatment naïve advanced‐stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi	HEMATOLOGICAL ONCOLOGY	2023
Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin's disease	FRONTIERS IN ONCOLOGY	2023
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi	HEMASPHERE	2023
Achieving the Cure of Follicular Lymphoma: is it Time to Finalize Treatment Strategies to Reach This Goal in a Subset of Patients?	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2023
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy	ANNALS OF HEMATOLOGY	2023
Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target	ASPECTS OF MOLECULAR MEDICINE	2023
Early clearance of hairy cell leukaemia in the bone marrow after first‐line treatment with cladribine predicts a favourable outcome	BRITISH JOURNAL OF HAEMATOLOGY	2023
Gilteritinib and the risk of intracranial hemorrhage: a case series of a possible, under-reported side effect	ANNALS OF HEMATOLOGY	2023
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma. A Fondazione Italiana Linfomi real-life experience	HEMATOLOGICAL ONCOLOGY	2022
Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment	CANCERS	2022
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study	HEMATOLOGICAL ONCOLOGY	2022
IMPACT OF PRE TRANSPLANT SALVAGE THERAPIES ON OUTCOME OF HODGKIN LYMPHOMA PATIENTS PERFORMING ALLOGENEIC TRANSPLANT	CHEMOTHERAPY	2022
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia	BRITISH JOURNAL OF HAEMATOLOGY	2022

Progetti di Ricerca

STUDIO RETROSPETTIVO SUL RUOLO PROGNOSTICO DELLA QUALITA' DELLA RISPOSTA ALLA PET DI FINE TRATTAMENTO VALUTATA SECONDO IL "DEAUVILLE SCORE", IN PAZIENTI CON LINFOMA DI HODGKIN CLASSICO, TRATTATI CON ABVD
RUOLO PROGNOSTICO DELLA PET DI FINE TRATTAMENTO NEL LINFOMA DI HODGKIN CLASSICO TRATTATO SECONDO SCHEMA ABVD: RIVALUTAZIONE CENTRALIZZATA DELLA PET SECONDO DEAUVILLE SCORE.